Cellebrite DI Ltd's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 56 out of 480 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 22.00.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Cellebrite DI Ltd is 8.89, ranking 23 out of 480 in the Software & IT Services industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 128.82M, representing a year-over-year increase of 18.13%, while its net profit experienced a year-over-year increase of 7.68%.
Key Metrics
The current valuation score of Cellebrite DI Ltd is 7.28, ranking 269 out of 480 in the Software & IT Services industry. Its current P/E ratio is 40.21, which is 44.06% below the recent high of 57.93 and 184.11% above the recent low of -33.82.
The current earnings forecast score of Cellebrite DI Ltd is 8.29, ranking 75 out of 480 in the Software & IT Services industry. The average price target is 24.00, with a high of 28.00 and a low of 23.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Cellebrite DI Ltd is 6.59, ranking 234 out of 480 in the Software & IT Services industry. Currently, the stock price is trading between the resistance level at 14.64 and the support level at 12.09, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Cellebrite DI Ltd is 5.00, ranking 226 out of 480 in the Software & IT Services industry. The latest institutional shareholding proportion is 62.11%, representing a quarter-over-quarter decrease of 2.39%. The largest institutional shareholder is James Simons, holding a total of 2.49M shares, representing 1.00% of shares outstanding, with 8.24% decrease in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Software & IT Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Cellebrite DI Ltd is 6.24, ranking 149 out of 480 in the Software & IT Services industry. The company's beta value is 1.26. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
